当前位置:首页 - 行情中心 - 君实生物-U(688180) - 财务分析 - 现金流量表

君实生物-U

(688180)

  

流通市值:214.07亿  总市值:275.99亿
流通股本:7.65亿   总股本:9.86亿

现金流量表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金1,334,950,275.33840,718,464.86396,310,961.151,474,934,030.73
收到的税费返还10,546,104.0910,546,104.09-143,929,288.86
收到其他与经营活动有关的现金51,386,223.2515,866,444.173,021,150.63122,669,834.99
经营活动现金流入的平衡项目0000
经营活动现金流入小计1,396,882,602.67867,131,013.12399,332,111.781,741,533,154.58
购买商品、接受劳务支付的现金1,319,202,006.33883,180,593.52433,711,376.042,082,560,054.82
支付给职工以及为职工支付的现金929,835,245.36666,064,219.15289,136,970.781,254,991,680.89
支付的各项税费69,060,203.9443,733,104.2723,365,530.9578,513,316.85
支付其他与经营活动有关的现金192,257,231.65139,504,767.7829,696,105.83330,450,198.99
经营活动现金流出的平衡项目0000
经营活动现金流出小计2,510,354,687.281,732,482,684.72775,909,983.63,746,515,251.55
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额-1,113,472,084.61-865,351,671.6-376,577,871.82-2,004,982,096.97
二、投资活动产生的现金流量:
收回投资收到的现金901,371,865.77250,000,000150,000,0001,246,870,799.38
取得投资收益收到的现金4,834,002.45389,043.54-4,234,520.55
处置固定资产、无形资产和其他长期资产收回的现金净额1,865,0001,865,000-4,097,167.34
收到的其他与投资活动有关的现金33,177,403.7824,983,805.714,082,716.54103,189,128.33
投资活动现金流入的平衡项目0000
投资活动现金流入小计941,248,272277,237,849.24164,082,716.541,358,391,615.6
购建固定资产、无形资产和其他长期资产支付的现金620,759,009.17395,713,348.07212,290,902.16832,574,528.57
投资支付的现金1,404,000,012.5830,000,00025,062,189.341,459,007,993.15
投资活动现金流出的平衡项目0000
投资活动现金流出小计2,024,759,021.671,225,713,348.07237,353,091.52,291,582,521.72
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-1,083,510,749.67-948,475,498.83-73,270,374.96-933,190,906.12
三、筹资活动产生的现金流量:
吸收投资收到的现金1,566.25--155,594,530.5
其中:子公司吸收少数股东投资收到的现金1,566.25--3,000,000
取得借款收到的现金1,928,788,474.471,434,543,532.271,277,906,362.64977,095,079.63
收到其他与筹资活动有关的现金4,641,807.393,725,476.58902,530.28207,889,063.78
筹资活动现金流入平衡项目0000
筹资活动现金流入小计1,933,431,848.111,438,269,008.851,278,808,892.921,340,578,673.91
偿还债务支付的现金943,497,136.23634,028,085.1730,000,000480,915,060.85
分配股利、利润或偿付利息支付的现金52,050,486.6533,862,165.9713,641,504.3738,226,802.11
支付其他与筹资活动有关的现金37,854,02927,995,206.6315,328,803.99109,609,030.99
筹资活动现金流出平衡项目0000
筹资活动现金流出小计1,033,401,651.88695,885,457.7758,970,308.36628,750,893.95
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额900,030,196.23742,383,551.081,219,838,584.56711,827,779.96
四、汇率变动对现金及现金等价物的影响-6,855,136.194,770,876.491,249,683.87,551,261.18
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-1,303,807,774.24-1,066,672,742.86771,240,021.58-2,218,793,961.95
加:期初现金及现金等价物余额3,778,142,035.883,778,142,035.883,778,142,035.885,996,935,997.83
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额2,474,334,261.642,711,469,293.024,549,382,057.463,778,142,035.88
补充资料:
净利润--687,709,041.49--2,535,689,297.85
资产减值准备-381,606.68-126,313,501.28
固定资产和投资性房地产折旧-123,119,142.4-248,629,278.03
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-123,119,142.4-248,629,278.03
无形资产摊销-15,755,581.48-23,695,564.99
长期待摊费用摊销-6,539,949.71-17,116,437.55
处置固定资产、无形资产和其他长期资产的损失--12,938,477.3--29,406,432.28
固定资产报废损失-618,756.85-520,267
公允价值变动损失-32,147,749.55-149,177,392.25
财务费用-3,341,025.46--57,756,280.09
投资损失-27,835,848.07--73,990,355.55
递延所得税-1,167,974.88-125,030,970.96
其中:递延所得税资产减少-1,167,974.88-125,030,970.96
存货的减少--24,938,026.09--32,448,335.17
经营性应收项目的减少-73,730,473.55--314,417,914.33
经营性应付项目的增加--438,357,576.19-262,671,653.75
其他-4,588,255.92-19,008,838.92
现金的期末余额-2,711,469,293.02-3,778,142,035.88
减:现金的期初余额-3,778,142,035.88-5,996,935,997.83
公告日期2024-10-302024-08-312024-04-302024-03-29
审计意见(境内)标准无保留意见
TOP↑